Effectiveness of treatments of depression in older ambulatory patients

Archives of Internal Medicine

Volumn 158, Issue 7, 1998, Pages 705-712

  McCusker, Jane ^a,b   Cole, Martin ^a,b   Keller, Evelyn ^d   Bellavance, François ^a,b   Berard, Anick ^a,c  

^a MCGILL UNIVERSITY   (Canada)

^b ST MARY S HOSPITAL   (Canada)

^c MCGILL UNIVERSITY   (Canada)

^d Clinique Roy Rousseau   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; SEROTONIN RECEPTOR;

ADULT; AGED; AGING; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; GERIATRIC PATIENT; HUMAN; MENTAL DISEASE; META ANALYSIS; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; PSYCHOTHERAPY; RATING SCALE; TREATMENT OUTCOME;

EID: 0032513515     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.158.7.705     Document Type: Article

References (71)

1. Anstey K, Brodaty H. Antidepressants and the elderly: double-blind trials 19871992. Int J Geriatr Psychiatry, 1995;10:265-279.
2. Gerson SC, Plotkin DA, Jarvik LF. Antidepressant drug studies, 1964 to 1986: empirical evidence for aging patients. J Clin Psychopharmacol. 1988;8:311-322.
3. Volz HP, Moller HJ. Antidepressant drug therapy in the elderly: a critical review of the controlled clinical trials conducted since 1980. Pharmacopsychiatry. 1994;27:93-100.
4. Scogin F, McElreath L. Efficacy of psychosocial treatments for geriatric depression: a quantitative review. J Consult Clin Psychol. 1994;62:69-74.
5. Depression Guideline Panel. Depression in Primary Care, 2: Treatment of Major Depression-Clinical Practice Guideline, No. 5. Washington, DC: US Dept of Health and Human Services, Agency for Health Care Policy and Research; 1993. Agency for Health Care Policy and Research publication 93-0551.
6. Schneider LJ, Reynolds CF, Lebowitz B, et al. Diagnosis and Treatment of Depression in Late Life: Results of the NIH Consensus Development Conference. Washington, DC: American Psychiatric Press; 1994.
7. Diagnostic and Statistical Manual of Mental Disorders, Third Edition. Washington, DC: American Psychiatric Association; 1980.
8. Diagnostic and Statistical Manual of Mental Disorders, Third Edition, Revised (DSM-III-R). Washington, DC: American Psychiatric Association; 1987.
9. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV). Washington, DC: American Psychiatric Association; 1994.
10. Feighner J, Robbins E, Guze S, et al. Diagnostic criteria for use in psychiatric research. Arch Gen Psychiatry. 1972;26:57-63.
11. Chalmers TC, Smith H Blackburn B, et al. A method for assessing the quality of a randomized control trial. Control Clin Trials. 1981;2:31-49.
12. Lin LI. A concordance correlation coefficient to evaluate reproducibility. Biometrics. 1989;45:255-268.
13. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23:56-62.
14. Hedges L, Olkin I. Statistical Methods for Meta-analysis. Orlando, Fla: Academic Press Inc; 1985.
15. Cooper H, Hedges LV. The Handbook of Research Synthesis. New York, NY: Russell Sage Foundation; 1994.
16. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177-188.
17. SAS Institute Inc. Version 6.10. Cary, NC: SAS Institute Inc; 1995.
18. Abraham IL, Neundorfer MM, Currie LJ. Effects of group interventions on cognition and depression in nursing home residents. Nurs Res. 1992;41:196-202.
19. Ames D. Depression among elderly residents of local-authority residential homes: its nature and the efficacy of intervention. Br J Psychiatry, 1990;156:667-675.
20. Beutler LE, Scogin F, Kirkish P, et al. Group cognitive therapy and alprazolam in the treatment of depression in older adults. J Consult Clin Psychol. 1987;55:550-556.
21. Blanchard M, Waterreus A, Mann A. The effect of primary care nurse intervention upon older people screened as depressed. Int J Geriatr Psychiatry. 1995;10:289-298.
22. Bohm C, Robinson DS, Gammans RE. Buspirone therapy for elderly patients with anxiety or depressive neurosis. J Clin Psychiatry. 1990;51:309.
23. Branconnier RJ, Cole JO, Ghazvinian S, Rosenthal S. Treating the depressed elderly patient: the comparative behavioral pharmacology of mianserin and amitriptyline. In: Costa E, Racagni G, eds. Typical and Atypical Antidepressants: Clinical Practice. New York, NY: Raven Press; 1982:195-212.
24. Callahan CM, Hendrie HC, Dittus RS, Brater CD, Hui SL, Tierney WM. Improving treatment of late life depression in primary care: a randomized clinical trial. J Am Geriatr Soc. 1994;42:839-849.
25. Cohn CK, Shrivastava R, Mendels J, et al. Double-blind, multicenter comparison of sertraline and amitriptyline in elderly demented patients. J Clin Psychiatry. 1990;51 (suppl B):28-30.
26. Cohn JB, Varga L, Lyfort A. A two-center double-blind study of nomifensine, imipramine, and placebo in depressed geriatric outpatients. J Clin Psychiatry. 1984;45:68-72.
27. Cook BL, Helms PM, Smith RE, Tsai M. Unipolar depression in the elderly: reoccurrence on discontinuation of tricyclic antidepressants. J Affect Disord. 1986;10:91-94.
28. DeLeo D, Ceola A, Magni G. Viloxazine against placebo in a double-blind study in depressed elderly patients. Curr Ther Res. 1984;36:239-244.
29. Dorman T. Sleep and paroxetine: a comparison with mianserin in elderly depressed patients. int Clin Psychopharmacol. 1992;6(suppl 4):53-58.
30. Dunner D, Cohn J, Walshe T, et al. Two combined, multicenter double-blind studies of paroxetine and doxepin in geriatric patients with major depression. J Clin Psychiatry. 1992;53(suppl):57-60.
31. Feighner JP, Boyer WF, Hendrickson GG, et al. A controlled trial of adinazolam versus desipramine in geriatric depression. Int Clin Psychopharmacol. 1990;5:227-232.
32. Feighner JP, Cohn JB. Double-blind comparative trials of fluoxetine and doxepin in geriatric patients with major depressive disorder. J Clin Psychiatry. 1985;46:20-25.
33. Fry PS. Structured and unstructured reminiscence training and depression among the elderly. Clin Gerontol. 1983;1:15-37.
34. Fry PS. Cognitive training and cognitive-behavioral variables in the treatment of depression in the elderly. Clin Gerontol. 1984;3:25-45.
35. Gallagher DE. Behavioral group therapy with elderly depressives: an experimental study. In: Upper D, Ross S, eds. Behavioral Group Therapy: An Annual Review. Champaign, III: Research Press; 1981:187-224.
36. Gallagher DE, Thompson LW. Treatment of major depressive disorder in older adult outpatients with brief psychotherapies. Psychother Theory Res Pract. 1982;19:482-490.
37. Gallagher DE, Hanley-Peterson P, Thompson LW. Maintenance of gains versus relapse following brief psychotherapy for depression. J Consult Clin Psychol. 1990;58:371-374.
38. Georgotas A, McCue RE. The additional benefit of extending an antidepressant trial past seven weeks in the depressed elderly. Int J Geriatr Psychiatry. 1989;4:191-195.
39. Georgotas A, McCue RE, Cooper TB. A placebo-controlled comparison of nortriptyline and phenelzine in maintenance therapy of elderly depressed patients. Arch Gen Psychiatry. 1986;46:783-786.
40. Georgotas A, McCue RE, Cooper TB, Nagachandran N, Chang I. How effective and safe is continuation therapy in elderly depressed patients? Arch Gen Psychiatry. 1988;45:929-932.
41. Georgotas A, McCue RE, Friedman E, Cooper TB. Response of depressive symptoms to nortriptyline, phenelzine and placebo. Br J Psychiatry. 1987:151:102-106.
42. Gerner R, Estabrook W, Steuer J, Waltuch P, Kakkar P, Jarvik L. A placebo controlled double-blind study of imipramine and trazodone in geriatric depression. In: Cole JO, Barrett JE, eds. Psychopathology in the Aged. New York NY: Raven Press; 1980:167-179.
43. Goldstein S, Birnbom F, Laliberte R. Nomifensine in treatment of depressed geriatric patients. J Clin Psychiatry. 1982;43.287-289.
44. Hostmaelingen HJ, Asskilt O, Austad SG, et al. Primary care treatment of depression in the elderly: a double-blind, multi-centre study of flupenthixol (Fluanxol) and sustained-release amitriptyline. Curr Med Res Opin. 1989;11:593-599.
45. Hutchinson DR, Tong S, Moon CA, Vince M, Clarke A. A double blind study in general practice to compare the efficacy and tolerability of paroxetine and amitriptyline in depressed elderly patients. Br J Clin Res. 1991;2:43-57.
46. Hutchinson DR, Tong S, Moon CAL, Vince M, Clarke A. Paroxetine in the treatment of elderly depressed patients in general practice: a double-blind comparison with amitriptyline. Int Clin Psychopharmacol. 1992;6:43-51.
47. Jarvik LF, Mintz J, Steuer J, Gerner R. Treating geriatric depression: a 26-week interim analysis. J Am Geriatr Soc. 1982;30:713-717.
48. Jenkins D, MacDonald A. Should general practitioners refer more of their elderly depressed patients to psychiatric services? Int J Geriatr Psychiatry. 1994;9:461-465.
49. Kane JM, Cole K, Sarantakos S, Howard A, Borenstein M. Safety and efficacy of bupropion in elderly patients: preliminary observations. J Clin Psychiatry. 1983;44:134-136.
50. Katz IR, Simpson GM, Curlik SM, Parmelee PA, Muhly C. Pharmacologic treatment of major depression for elderly patients in residential care settings. J Clin Psychiatry. 1990;51(suppl):41-47.
51. Kivela S-L, Lehtomaki E. Sulpiride placebo in depressed elderly outpatients: a double-blind study. Int J Geriatr Psychiatry. 1987;2:255-260.
52. Merideth CH, Feighner JP, Hendrickson G. A double-blind comparative evaluation of the efficacy and of nomifensine, imipramine, and placebo in depressed geriatric outpatients. J Clin Psychiatry. 1984;45:73-77.
53. Nair VN, Amin M, Schwartz G, et al. A comparison of the cardiac safety and therapeutic efficacy of trimipramine versus doxepin in geriatric depressed patients. J Am Geriatr Soc. 1993;41:863-867.
54. Old Age Depression Interest Group. How long should the elderly take antidepressants? a double-blind placebo-controlled study of continuation/ prophylaxis therapy with Dothiepin. Br J Psychiatry. 1993;162:175-182.
55. Ong Y-L, Martineau F, Lloyd C, Robbins I. A support group for the depressed elderly. Int J Geriatr Psychiatry. 1987;2:119-123.
56. Pancheri P, Dellechiaie R, Donnini M, et al. Effects of moclobemide on depressive symptoms and cognitive performance in a geriatric population: a controlled comparative study versus imipramine. Clin Neuropharmacol. 1994;17(suppl 1): S58-S73.
57. Sallis JF, Lichstein KL, Clarkson AD, Stalgaitis S, Campbell M. Anxiety and depression management for the elderly. Int J Behav Geriatr. 1983;1:3-12.
58. Schone W, Ludwig M. A double-blind study of paroxetine compared with fluoxetine in geriatric patients with major depression. J Clin Psychopharmacol. 1993;13(suppl 2):34S-39S.
59. Scogin F, Hamblin D, Beutler L. Bibliotherapy for depressed older adults: a self-help alternative. Gerontologist. 1987;27:383-387.
60. Scogin F, Jamison C, Gochneaur K. Comparative efficacy of cognitive and behavioral bibliotherapy for mildly and moderately depressed older adults. J Consult Clin Psychol. 1989;57:403-407.
61. Scogin F, Jamison C, Davis N. Two-year follow-up of bibliotherapy for depression in older adults. J Consult Clin Psychol. 1990;58:665-667.
62. Sloane BA, Staples FR, Schneider LS. Interpersonal therapy versus nortriptyline for depression in the elderly. In: Burrows GD, Norman TR, Dennerstein L, eds. Clinical and Pharmacological Studies in Psychiatric Disorders. London, England: John Libbey; 1985.
63. Steuer JL, Mintz J, Hammen CL, et al. Cognitive-behavioral and psychodynamic group psychotherapy in treatment of geriatric depression. J Consult Clin Psychol. 1984;52:180-189.
64. Thompson LW, Gallagher D, Breckenridge JS. Comparative effectiveness of psychotherapies for depressed elders. J Consult Clin Psychol. 1987;55:385-390.
65. Tollefson GD, Holman SL. Analysis of the Hamilton Depression Rating Scale factors from a double-blind, placebo-controlled trial of fluoxetine in geriatric major depression. Int Clin Psychopharmacol. 1993;8:253-259.
66. Weissman MM, Prusoff B, Sholomskas AJ, Greenwald S. A double-blind clinical trial of alprazolam, imipramine, or placebo in the depressed elderly. J Clin Psychopharmacol. 1992;12:175-182.
67. Zung W, Gianturco D, Pfeiffer E, Wang H, Potkins S. Pharmacology of depression in the aged: evaluation of Gerovital H-3 as an antidepressant drug. Psychosomatics. 1974;15:127-131.
68. Sackett DL, Snow JC. The magnitude of compliance and non-compliance. In: Haynes RB, Taylor W, Sackett DL, eds. Compliance in Health Care. Baltimore, Md: Johns Hopkins Press; 1979.
69. Cole MG. The course of elderly depressed outpatients. Can J Psychiatry. 1985;30:217-220.
70. Schulberg HC, Coulehan JL, Block MR, Scott PC, Imber SD, Perel JM. Strategies for evaluating treatments for major depression in primary care patients. Gen Hosp Psychiatry. 1991;13:9-18.
71. Buck C, Donner A. The design of controlled experiments in the evaluation of nontherapeutic interventions. J Chronic Dis. 1982;35:531-538.